Impact of Long-Term Warfarin Treatment on EVAR Durability: A Meta-Analysis
Authors:
- George S. GeorgiadisGGGeorge S. Georgiadis
- Dimitrios G. CharalampidisDCDimitrios G. Charalampidis
- George A. AntoniouGAGeorge A. Antoniou
- Efstratios I. GeorgakarakosEGEfstratios I. Georgakarakos
- George TrellopoulosGTGeorge Trellopoulos
- 1 February 2014
- journal article
- research article
- Published by International Society of Endovascular Specialists in Journal of Endovascular Therapy
- Vol. 21 (1) , 148-153
Abstract
To evaluate whether postoperative long-term oral anticoagulation affects the durability of endovascular aneurysm repair (EVAR) and whether it is associated with an increased incidence of endoleak and subsequent need for reintervention. A literature search was performed to identify studies of abdominal aortic aneurysm patients undergoing EVAR including an arm receiving warfarin postoperatively and reporting the frequency of any endoleaks and/or persistent type II endoleaks and reinterventions. The search identified 81 articles, of which 5 observational cohort studies ultimately met the inclusion criteria. Postoperative anticoagulation was required in 219 (14.6%) of the 1499 patients in the selected studies. The pooled effects analysis found that EVAR patients receiving long-term warfarin postoperatively had significantly more endoleaks of any type (OR 1.77, 95% CI 1.26 to 2.48, p=0.001) as well as persistent type II endoleaks (OR 1.58, 95% CI 1.05 to 2.37, p=0.03) compared with patients not on anticoagulation; however, there was no statistically significant difference in the reintervention rate between the groups. Long-term anticoagulation in EVAR patients was associated with a statistically significant increase in any endoleak and persisting type II endoleaks, although it was not linked to an increased risk of reintervention. Close monitoring for EVAR patients who require long-term oral anticoagulation is advised.Keywords
This publication has 16 references indexed in Scilit:
- Effect of chronic oral anticoagulation with warfarin on the durability and outcomes of endovascular aortic aneurysm repairJournal of Vascular Surgery, 2013
- The effect of warfarin therapy on endoleak development after endovascular aneurysm repair (EVAR) of the abdominal aortaJournal of Vascular Surgery, 2010
- Preoperative variables predict persistent type 2 endoleak after endovascular aneurysm repairJournal of Vascular Surgery, 2010
- Reversible endotension associated with excessive warfarin anticoagulationJournal of Vascular Surgery, 2007
- Does Chronic Oral Anticoagulation With Warfarin Affect Durability of Endovascular Aortic Aneurysm Exclusion in a Midterm Follow-up?Journal of Endovascular Therapy, 2005
- Technique and results of transfemoral superselective coil embolization of type II lumbar endoleakJournal of Vascular Surgery, 2003
- Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examinationJournal of Vascular Surgery, 2002
- Endoleak after endovascular repair of abdominal aortic aneurysmJournal of Vascular Surgery, 2001
- Retroperitoneal endoscopic ligation of lumbar and inferior mesenteric arteries as a treatment of persistent endoleak after endoluminal aortic aneurysm repairJournal of Vascular Surgery, 2000
- Rupture of abdominal aortic aneurysm previously treated by endovascular stentgraftJournal of Vascular Surgery, 1998